ReviewCancers2023

Targeting Class I-II-III PI3Ks in Cancer Therapy: Recent Advances in Tumor Biology and Preclinical Research.

Benoît Thibault et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.